platoseedplatoseed
Neural interfaces to understand and use nerve data in medicine.
BIOS Health was previously called Cambridge Bio-Augmentation Systems (CBAS) and focused on prosthetic neural interfaces as a first market. Now we use
BIOS Health is developing AI-powered neural interfaces to read and write nervous system data for digital health therapies, starting with cardiovascular conditions. They aim to enable real-time insights and personalized, software-delivered neural treatments to improve precision medicine for chronic diseases.
BIOS has created neural interfaces and an AI platform that can measure and analyze neural data in real-time in acute and chronic settings. They describe a neural 'code' for the nervous system and a Neural Dosing Platform that combines neural recordings with AI/ML to personalize neural therapies within minutes. The technology supports real-time feedback to influence drug effects and delivers potential neural digital therapies and software-delivered treatments targeting the nervous system.
Who it’s for: Pharmaceutical companies, clinical researchers, and health systems seeking precision, data-driven neural therapies for chronic diseases, starting with cardiovascular conditions.
Hiring (Cambridge and Montreal); mentions partnerships and funding coverage; media highlights and awards indicate traction
Formerly “Cambridge Bio-Augmentation Systems” · why startups rename →
We grow cells for biotech companies.
Brain Longevity
